9.25
price down icon1.70%   -0.15
 
loading

Finanzdaten der Rezolute Inc-Aktie (RZLT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
17.23%
20.02
17.08 16.94 23.10 16.21
Depreciation and Amortization
12.50%
0.007
0.008 0.008 0.007 0.009
Operating Income/Loss
17.23%
-20.02
-17.08 -16.94 -23.10 -16.21
Nonoperating Income/Loss
17.85%
1.109
1.35 1.563 0.126 -0.837
Income/Loss From Continuing Operations Before Tax
20.24%
-18.91
-15.73 -15.38 -22.98 -17.05
Income/Loss From Continuing Operations After Tax
20.24%
-18.91
-15.73 -15.38 -22.98 -17.05
Net Income/Loss
20.24%
-18.91
-15.73 -15.38 -22.98 -17.05
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.13%
70.03
69.94 69.74 0.253 50.81
Diluted Average Shares
0.13%
70.03
69.94 69.74 0.253 50.81
Basic Earnings Per Share
22.73%
-0.27
-0.22 -0.22 -0.44 -0.34
Diluted Earnings Per Share
22.73%
-0.27
-0.22 -0.22 -0.44 -0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.83
price up icon 1.66%
$85.75
price up icon 1.10%
$31.46
price up icon 2.62%
$102.62
price up icon 4.05%
$144.22
price up icon 0.15%
biotechnology ONC
$342.98
price up icon 0.67%
Kapitalisierung:     |  Volumen (24h):